Root Financial Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Root Financial Partners's VRTX Position: Q3 2026 in Review
Root Financial Partners increased its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q3 2026, buying an estimated $2.56K and bringing the position to 479 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #360.
Root Financial Partners first reported a position in VRTX in Q3 2025 and has held it in 5 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Root Financial Partners held 479 shares of Vertex Pharmaceuticals worth $250K as of Q3 2026.
- Root Financial Partners bought 5 Vertex Pharmaceuticals shares in Q3 2026, an estimated $2.56K.
- Vertex Pharmaceuticals made up 0.01% of Root Financial Partners's portfolio in Q3 2026, its #360 holding.
- Root Financial Partners first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.